{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:18:04Z","timestamp":1760015884416},"reference-count":19,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.biologicals.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T02:01:01Z","timestamp":1371693661000},"page":"275-278","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: Its application in\u00a0identity tests"],"prefix":"10.1016","volume":"41","author":[{"given":"F\u00e1tima","family":"Reyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevis","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"27 Suppl. 2","key":"10.1016\/j.biologicals.2013.05.002_bib1","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.05.002_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/archdischild-2012-302036","article-title":"Prospects for eradication of meningococcal disease","volume":"97","author":"Nadel","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.biologicals.2013.05.002_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biologicals.2012.07.011","article-title":"In\u00a0vitro antigen ELISA for quality control of tetanus vaccines","volume":"40","author":"Coombes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2013.05.002_bib4","series-title":"Fifty-seventh report. Technical report series no. 962","first-page":"115","article-title":"Annex 2, guidelines for assuring the quality, safety and efficacy of meningococcocal A conjugate vaccines","author":"WHO Expert Committee on Biological Standardization","year":"2006"},{"key":"10.1016\/j.biologicals.2013.05.002_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ab.2004.12.002","article-title":"Determination of meningococcal polysaccharides by capillary zone electrophoresis","volume":"338","author":"Lamb","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2013.05.002_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/JCM.29.7.1447-1452.1991","article-title":"Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents","volume":"29","author":"Nato","year":"1991","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.biologicals.2013.05.002_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/CDLI.12.1.152-156.2005","article-title":"Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay","volume":"12","author":"Tsang","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biologicals.2013.05.002_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2013.05.002_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2013.05.002_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biologicals.2013.05.002_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/CVI.00049-07","article-title":"Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis","volume":"14","author":"Moore","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2013.05.002_bib12","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","article-title":"Relative stability of meningococcal serogroup A and X polysaccharides","volume":"30","author":"Berti","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.05.002_bib13","first-page":"154","article-title":"Measurement of affinity constant of anti-human IgG monoclonal antibodies by an ELISA-based method","volume":"1","author":"Hajighasemi","year":"2004","journal-title":"IJI"},{"key":"10.1016\/j.biologicals.2013.05.002_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2010.12.001","article-title":"The consistency approach for quality control of vaccines \u2013 a strategy to improve quality control and implement 3Rs","volume":"39","author":"De Mattia","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2013.05.002_bib15","series-title":"Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies","author":"U.S. Department of Health and Human Services Food and Drug Administration","year":"1997"},{"key":"10.1016\/j.biologicals.2013.05.002_bib16","first-page":"28","article-title":"Spectroscopy to obtain the higher order structure of biopharmaceutical products","author":"Aubin","year":"2010","journal-title":"Biopharm Int Suppl"},{"key":"10.1016\/j.biologicals.2013.05.002_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/biol.2000.0255","article-title":"An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b","volume":"28","author":"Lemercinier","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2013.05.002_bib18","first-page":"43","article-title":"Western Blot technique as an identity criterion for Men B antimeningococcal vaccine","author":"Di\u00e9guez","year":"2009","journal-title":"Revista Cubana de Farmacia"},{"key":"10.1016\/j.biologicals.2013.05.002_bib19","series-title":"Fiftieth report. Technical report series no. 904","first-page":"94","article-title":"Annex 2, requirements for meningococcal polysaccharide vaccine (Amendment 1999)","author":"WHO Expert Committee on Biological Standardization","year":"2002"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T20:15:03Z","timestamp":1595967303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105613000559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1045105613000559"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.05.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: Its application in\u00a0identity tests","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}